Ohm Laboratories to launch generic hypertension drug in US


Ohm Laboratories Inc, a wholly owned subsidiary of Indian Ranbaxy Laboratories, which has been facing regulatory hurdles in the US, has been allowed by the US Food and Drug Administration to manufacture and market generic Valsartan tablets with 180 days of marketing exclusivity…

Read the source article at Business Standard

About the Author

Leave a Reply